• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性结直肠癌切除术后的实际生存率:一项前瞻性多中心研究的结果

Actual survival after resection of primary colorectal cancer: results from a prospective multicenter study.

作者信息

van den Berg Inge, Coebergh van den Braak Robert R J, van Vugt Jeroen L A, Ijzermans Jan N M, Buettner Stefan

机构信息

Department of Surgery, Erasmus MC - University Medical Center Rotterdam, Rotterdam, 3015 GD, The Netherlands.

出版信息

World J Surg Oncol. 2021 Apr 5;19(1):96. doi: 10.1186/s12957-021-02207-4.

DOI:10.1186/s12957-021-02207-4
PMID:33820567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8022415/
Abstract

BACKGROUND

Colorectal cancer is the third most common type of cancer in the world. We characterize a cohort of patients who survived up to 5 years without recurrence and identify factors predicting the probability of cure.

METHODS

We analyzed data of patients who underwent curative intent surgery for stage I-III CRC between 2007 and 2012 and who had had been included in a large multicenter study in the Netherlands. Cure was defined as 5-year survival without recurrence. Survival data were retrieved from a national registry.

RESULTS

Analysis of data of 754 patients revealed a cure rate of 65% (n = 490). Patients with stage I disease and T1- and N0-tumor had the highest probability of cure (94%, 95% and 90%, respectively). Those with a T4-tumor or N2-tumor had the lowest probability of cure (62% and 50%, respectively). A peak in the mortality rate for older patients early in follow-up suggests early excess mortality as an explanation. A similar trend was observed for stage III disease, poor tumor grade, postoperative complications, sarcopenia, and R1 resections. Patients with stage III disease, poor tumor grade, postoperative complications, sarcopenia, and R1 resections show a similar trend for decrease in CSS deaths over time.

CONCLUSION

In the studied cohort, the probability of cure for patients with stage I-III CRC ranged from 50 to 95%. Even though most patients will be cured from CRC with standard therapy, standard therapy is insufficient for those with poor prognostic factors, such as high T- and N-stage and poor differentiation grade.

摘要

背景

结直肠癌是全球第三大常见癌症类型。我们对一组存活达5年且无复发的患者进行了特征分析,并确定了预测治愈可能性的因素。

方法

我们分析了2007年至2012年间接受I - III期结直肠癌根治性手术且纳入荷兰一项大型多中心研究的患者数据。治愈定义为5年无复发存活。生存数据从国家登记处获取。

结果

对754例患者的数据进行分析显示,治愈率为65%(n = 490)。I期疾病以及T1和N0期肿瘤的患者治愈概率最高(分别为94%、95%和90%)。T4期肿瘤或N2期肿瘤的患者治愈概率最低(分别为62%和50%)。随访早期老年患者死亡率出现峰值,提示早期额外死亡率可作为一种解释。III期疾病、肿瘤分级差、术后并发症、肌肉减少症和R1切除也观察到类似趋势。III期疾病、肿瘤分级差、术后并发症、肌肉减少症和R1切除的患者随着时间推移CSS死亡减少呈现类似趋势。

结论

在本研究队列中,I - III期结直肠癌患者的治愈概率为50%至95%。尽管大多数患者通过标准治疗可治愈结直肠癌,但对于具有高T和N分期以及低分化分级等不良预后因素的患者,标准治疗并不充分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/8022415/f3752d79c687/12957_2021_2207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/8022415/620ef988f9d0/12957_2021_2207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/8022415/9e1d4cb7e046/12957_2021_2207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/8022415/f3752d79c687/12957_2021_2207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/8022415/620ef988f9d0/12957_2021_2207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/8022415/9e1d4cb7e046/12957_2021_2207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/8022415/f3752d79c687/12957_2021_2207_Fig3_HTML.jpg

相似文献

1
Actual survival after resection of primary colorectal cancer: results from a prospective multicenter study.原发性结直肠癌切除术后的实际生存率:一项前瞻性多中心研究的结果
World J Surg Oncol. 2021 Apr 5;19(1):96. doi: 10.1186/s12957-021-02207-4.
2
Long-term oncological outcomes of endoscopic full-thickness resection after previous incomplete resection of low-risk T1 CRC (LOCAL-study): study protocol of a national prospective cohort study.内镜全层切除术治疗低危 T1CRC 既往不完全切除的长期肿瘤学结局(LOCAL 研究):一项全国前瞻性队列研究的研究方案。
BMC Gastroenterol. 2022 Dec 13;22(1):516. doi: 10.1186/s12876-022-02591-5.
3
A competing risk analysis of colorectal cancer recurrence after curative surgery.根治性手术后结直肠癌复发的竞争风险分析。
BMC Gastroenterol. 2022 Mar 3;22(1):95. doi: 10.1186/s12876-022-02161-9.
4
Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.十年间结肠癌和直肠癌的手术结果:来自902例未经选择患者的连续单中心经验结果。
World J Surg Oncol. 2007 Jul 4;5:73. doi: 10.1186/1477-7819-5-73.
5
Laparoscopic surgery for the cure of colorectal cancer: results of a German five-center study.腹腔镜手术治疗结直肠癌:一项德国五中心研究的结果
Dis Colon Rectum. 2000 Jan;43(1):1-8. doi: 10.1007/BF02237235.
6
Potentially curative resection for locoregional recurrence of colorectal cancer.结直肠癌局部区域复发的潜在根治性切除术。
Surg Today. 2004;34(11):907-12. doi: 10.1007/s00595-004-2816-3.
7
Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer.与结直肠癌患者肿瘤切除术后并发症相关的临床病理参数,以及肿瘤复发和死亡的危险因素。
Clin Transl Oncol. 2018 Feb;20(2):176-192. doi: 10.1007/s12094-017-1708-0. Epub 2017 Jul 14.
8
Aspects of survival from colorectal cancer in Denmark.丹麦结直肠癌的生存情况
Dan Med J. 2012 Apr;59(4):B4428.
9
Disease recurrence after colorectal cancer surgery in the modern era: a population-based study.结直肠癌手术后疾病复发的现代研究:基于人群的研究。
Int J Colorectal Dis. 2021 Nov;36(11):2399-2410. doi: 10.1007/s00384-021-03914-w. Epub 2021 Apr 4.
10
Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials.外科质量和淋巴结超分期与早期结直肠癌的长期无病生存相关:两项国际多中心前瞻性试验的分析。
Ann Surg. 2010 Sep;252(3):467-74; discussion 474-6. doi: 10.1097/SLA.0b013e3181f19767.

引用本文的文献

1
Long-Term Prognostic Outcomes of Right Hemicolectomy and Extended Right Hemicolectomy Performed for Hepatic Flexura and Proximal Transverse Colon Tumors.肝曲和近端横结肠肿瘤行右半结肠切除术及扩大右半结肠切除术的长期预后结果
Cancer Control. 2025 Jan-Dec;32:10732748251376793. doi: 10.1177/10732748251376793. Epub 2025 Sep 4.
2
The role of tumor characteristics and biomarkers in predicting long-term survival rates of rectal cancer patients.肿瘤特征和生物标志物在预测直肠癌患者长期生存率中的作用。
Medicine (Baltimore). 2025 Aug 8;104(32):e43799. doi: 10.1097/MD.0000000000043799.
3
Isoperistaltic Side-to-side Anastomosis in Colorectal Surgery: Outcomes and Comparative Insights from Bahrain.

本文引用的文献

1
PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases.PROPHYLOCHIP研究:结直肠癌腹膜转移患者接受二次手术加腹腔热灌注化疗无获益。
Lancet Oncol. 2020 Sep;21(9):1124-1125. doi: 10.1016/S1470-2045(20)30338-7. Epub 2020 Jul 24.
2
The long-term survival characteristics of a cohort of colorectal cancer patients and baseline variables associated with survival outcomes with or without time-varying effects.具有时变效应的生存结局及无时间变异性生存结局的结直肠癌患者队列的长期生存特征及其相关基线变量。
BMC Med. 2019 Jul 29;17(1):150. doi: 10.1186/s12916-019-1379-5.
3
The effects of comorbidity on colorectal cancer mortality in an Australian cancer population.
结直肠手术中的等蠕动侧侧吻合术:巴林的结果及比较见解
Euroasian J Hepatogastroenterol. 2025 Jan-Jun;15(1):44-49. doi: 10.5005/jp-journals-10018-1469. Epub 2025 Jun 18.
4
Competing risk and random survival forest models for predicting survival in post-resection elderly stage I-III colorectal cancer patients.用于预测I-III期老年结直肠癌患者术后生存情况的竞争风险和随机生存森林模型
Sci Rep. 2025 Jul 7;15(1):24269. doi: 10.1038/s41598-025-05824-1.
5
Utility of C-reactive protein on the fourth postoperative day to detect complications beyond anastomotic dehiscence.术后第四天C反应蛋白在检测除吻合口裂开之外的并发症方面的效用。
Int J Colorectal Dis. 2025 May 20;40(1):124. doi: 10.1007/s00384-025-04912-y.
6
MicroRNA-122 overexpression suppresses the colon cancer cell proliferation by downregulating the astrocyte elevated gene-1/metadherin oncoprotein.微小RNA-122的过表达通过下调星形胶质细胞升高基因-1/黏附素原癌蛋白来抑制结肠癌细胞增殖。
Ann Med. 2025 Dec;57(1):2478311. doi: 10.1080/07853890.2025.2478311. Epub 2025 Apr 10.
7
Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors.不同种族和族裔群体之间的结直肠癌死亡率差异:社会经济地位、临床病理及治疗相关因素的影响
Cancer Med. 2025 Mar;14(5):e70612. doi: 10.1002/cam4.70612.
8
Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study.循环肿瘤DNA作为III期结直肠癌复发风险的标志物:α-CORRECT研究。
J Surg Oncol. 2025 Jul;132(1):175-186. doi: 10.1002/jso.27989. Epub 2025 Jan 25.
9
The Determinants of Long-Term Outcomes After Colorectal Cancer Surgery: A Literature Review.结直肠癌手术后长期预后的决定因素:文献综述
Cureus. 2024 Dec 2;16(12):e74985. doi: 10.7759/cureus.74985. eCollection 2024 Dec.
10
Achieving Health Equity: Advancing Colorectal Surgery among Racial and Ethnic Minorities in America.实现健康公平:促进美国少数族裔中的结直肠手术发展。
Clin Colon Rectal Surg. 2024 May 13;38(1):34-40. doi: 10.1055/s-0044-1786532. eCollection 2025 Jan.
澳大利亚癌症人群中合并症对结直肠癌死亡率的影响。
Sci Rep. 2019 Jun 12;9(1):8580. doi: 10.1038/s41598-019-44969-8.
4
Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.应用非参数非混合治愈率模型分析伊朗结直肠癌患者的生存情况。
Epidemiol Health. 2018;40:e2018045. doi: 10.4178/epih.e2018045. Epub 2018 Sep 17.
5
Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.更频繁与不那么频繁的随访检测对 II 期或 III 期结直肠癌患者总死亡率和结直肠癌特异性死亡率的影响:COLOFOL 随机临床试验。
JAMA. 2018 May 22;319(20):2095-2103. doi: 10.1001/jama.2018.5623.
6
Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?结直肠肝转移灶切除术后的 10 年实际生存率:哪些因素妨碍治愈?
Surgery. 2018 Jun;163(6):1238-1244. doi: 10.1016/j.surg.2018.01.004. Epub 2018 Feb 15.
7
Systematic Second-look Surgery Plus HIPEC in Patients Without Evidence of Recurrence, at High Risk of Carcinomatosis After Colorectal Cancer Resection.结直肠癌切除术后无复发证据但存在癌性腹膜炎高风险患者的系统性二次探查手术加腹腔热灌注化疗
Cir Esp (Engl Ed). 2018 Feb;96(2):96-101. doi: 10.1016/j.ciresp.2017.11.006. Epub 2018 Feb 3.
8
Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract.低骨骼肌质量与接受消化道癌症手术患者的住院费用增加有关。
PLoS One. 2017 Oct 31;12(10):e0186547. doi: 10.1371/journal.pone.0186547. eCollection 2017.
9
A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer.原发性结肠癌致癌基因融合的系统分析。
Cancer Res. 2017 Jul 15;77(14):3814-3822. doi: 10.1158/0008-5472.CAN-16-3563. Epub 2017 May 16.
10
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.超越TNM系统的II期和III期结肠癌总生存期预测:一项回顾性、汇总生物标志物研究
Ann Oncol. 2017 May 1;28(5):1023-1031. doi: 10.1093/annonc/mdx052.